Results 181 to 190 of about 7,977 (217)
Some of the next articles are maybe not open access.
Best Practice & Research Clinical Endocrinology & Metabolism
Prolactinomas (lactotroph pituitary neuroendocrine tumours) account for almost half of all pituitary tumours and significantly affect quality of life. Dopamine agonists (DA) are effective in achieving biochemical control in prolactinoma, but rates of long-term biochemical remission off therapy are low, and there is an increasing recognition of a broad ...
Mendel, Castle-Kirszbaum, Ann, McCormack
openaire +2 more sources
Prolactinomas (lactotroph pituitary neuroendocrine tumours) account for almost half of all pituitary tumours and significantly affect quality of life. Dopamine agonists (DA) are effective in achieving biochemical control in prolactinoma, but rates of long-term biochemical remission off therapy are low, and there is an increasing recognition of a broad ...
Mendel, Castle-Kirszbaum, Ann, McCormack
openaire +2 more sources
Archives of Pediatrics & Adolescent Medicine, 1987
Sir .—I read with great interest the report by Huseman and colleagues 1 on a child with prolactinoma. The letter was extremely valuable in pointing the efficacy of bromocriptine therapy even in large tumors. It is reassuring to read that this conservative approach to treatment is as efficacious in children as it is in adults.
openaire +2 more sources
Sir .—I read with great interest the report by Huseman and colleagues 1 on a child with prolactinoma. The letter was extremely valuable in pointing the efficacy of bromocriptine therapy even in large tumors. It is reassuring to read that this conservative approach to treatment is as efficacious in children as it is in adults.
openaire +2 more sources
The Netherlands journal of medicine, 2010
Prolactinomas are a frequent cause of gonadal dysfunction and infertility, especially in women. Dopamine agonists are first-line therapy and their efficacy in the treatment of prolactinomas is well established. Current challenges related to the management of prolactinomas remain in the recurrence of the disease after withdrawal of dopamine agonists ...
Kars, M. +3 more
openaire +3 more sources
Prolactinomas are a frequent cause of gonadal dysfunction and infertility, especially in women. Dopamine agonists are first-line therapy and their efficacy in the treatment of prolactinomas is well established. Current challenges related to the management of prolactinomas remain in the recurrence of the disease after withdrawal of dopamine agonists ...
Kars, M. +3 more
openaire +3 more sources
Pituitary, 2005
Prolactinomas are the most frequent pituitary tumors. Treatment of infertility in such tumors usually is very successful. On the other hand, reports of pituitary tumor growth during pregnancy have been described since bromocriptine started to be used.
openaire +2 more sources
Prolactinomas are the most frequent pituitary tumors. Treatment of infertility in such tumors usually is very successful. On the other hand, reports of pituitary tumor growth during pregnancy have been described since bromocriptine started to be used.
openaire +2 more sources
Best Practice & Research Clinical Endocrinology & Metabolism, 2011
Prolactinomas commonly cause infertility and treatment usually restores ovulation and fertility. The dopamine agonists are the preferred mode of treatment, with cabergoline generally being preferred to bromocriptine because of its higher therapeutic ratio.
openaire +2 more sources
Prolactinomas commonly cause infertility and treatment usually restores ovulation and fertility. The dopamine agonists are the preferred mode of treatment, with cabergoline generally being preferred to bromocriptine because of its higher therapeutic ratio.
openaire +2 more sources
Hyperprolactinemia and prolactinoma
2014Prolactinomas are the most frequent pituitary adenomas. In patients with prolactinomas the primary cause of hyperprolactinemia is excessive and autonomic production of prolactin by lactotroph cells. In other conditions, except in case of macroprolactinemia, hyperprolactinemia is secondary to circumstances that stimulate secretion of prolactin by ...
openaire +3 more sources
Archives of Internal Medicine, 1979
In the past ten years, hyperprolactinemia has been implicated as a possible cause of several common medical problems. One of the first recognized was the so-called amenorrhea-galactorrhea syndrome. Subsequently it was learned that not all patients with elevated prolactin levels have galactorrhea 1 (only about 20% of hyperprolactinemic women and even ...
openaire +2 more sources
In the past ten years, hyperprolactinemia has been implicated as a possible cause of several common medical problems. One of the first recognized was the so-called amenorrhea-galactorrhea syndrome. Subsequently it was learned that not all patients with elevated prolactin levels have galactorrhea 1 (only about 20% of hyperprolactinemic women and even ...
openaire +2 more sources
BJOG: An International Journal of Obstetrics & Gynaecology, 2000
H S, Randeva, M, Davis, G M, Prelevic
openaire +2 more sources
H S, Randeva, M, Davis, G M, Prelevic
openaire +2 more sources